BioStock: AdjuTec CEO aims for better and safer antibiotics

Norwegian pharmaceutical company AdjuTec Pharma is on a mission to combat the growing threat of antimicrobial resistance. The company is developing antibiotic resistance breakers, focusing on β-lactamase inhibitors. BioStock contacted CEO Bjørn Klem to learn more about the development and what lies ahead for the company.

Read the full article at biostock.se:

https://www.biostock.se/2023/09/adjutec-ceo-aims-for-better-and-safer-antibiotics/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se